Company Profile

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.

Contact Information

Investor Relations
Jed Latkin
Chief Financial and Operating Officer
T: 614-973-7490

Edison Advisors
Tirth Patel
Vice President, Investor Relations
295 Madison Avenue, 18th Floor
New York, NY 10017
T: 646-653-7035

Company Contact
Navidea Biopharmaceuticals, Inc.
4995 Bradenton Avenue
Dublin, OH 43017